Search

everythinglearnresearchcommunity

for

Search:↓

Some common medications can lower PSA levels in 45-year-old German men.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Early baldness in men may indicate a higher risk of prostate cancer.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Higher cholesterol levels increase aggressive prostate cancer risk.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Men with pattern baldness may have a higher risk of prostate issues.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

CEC levels may be a useful marker for predicting prostate cancer progression.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.